advertisement
This update provides a comprehensive review of neovascular glaucoma with respect to terminology, etiology, pathology, diagnosis, and management. It is stressed that prevention is better than cure and that late presentation of well established neovascular glaucoma is often associated with a poor outcome. Although the outcome of filtration procedures may be improved by adjunctive therapy with agents, such as mitomycin C, the evidence for this is relatively weak. Furthermore, although the introduction of cyclodiode as a more predictable cycloablative procedure has the potential to improve outcomes, larger long-term studies are required to fully assess its effectiveness. In the future, it is hoped that specific antiangiogenic therapies will become available to improve the outcome of a disease that can result in painful blindness.
D.C. Broadway, MD, Department of Ophthalmology, Norfold & Norwich University Hospital, Colney Lane, Norwich, Norfolk, NR4 7UZ, UK. david-broadway@norfolk-norwich.thenhs.com
9.4.5.1 Neovascular glaucoma (Part of: 9 Clinical forms of glaucomas > 9.4 Glaucomas associated with other ocular and systemic disorders > 9.4.5 Glaucomas associated with disorders of the retina, choroid and vitreous)